[Surgical treatment of pulmonary aspergilloma]

T Schulte1, K Welcker, J Schatz

  • 1Klinik für Chirurgie, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany.

Mycoses
|April 14, 2005
PubMed

Insights

Invasive pulmonary aspergillosis, often caused by Aspergillus fumigatus, is a severe infection primarily affecting immunocompromised individuals. Surgical resection following anatomical borders offers a viable treatment option with acceptable outcomes.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Surgical Oncology

Background:

  • Invasive pulmonary aspergillosis is a life-threatening opportunistic infection.
  • It predominantly affects immunocompromised patients, including those with AIDS or malignomas, and can follow tuberculosis.
  • Hemoptysis, ranging from mild to massive bleeding, is a common symptom and complication.

Purpose of the Study:

  • To outline the indications and surgical management of pulmonary aspergilloma.
  • To emphasize the importance of multidisciplinary discussion between surgeons and pulmonologists for optimal timing and approach.
  • To detail the surgical techniques for resection and management of residual cavities.

Main Methods:

  • Surgical resection of pulmonary aspergilloma is indicated.
  • Resection should adhere to anatomical planes, such as lobectomy or pneumectomy.
  • Intrathoracic cavities require obliteration using lung tissue, muscle flaps (latissimus, pectoralis), or omentum majus.

Main Results:

  • Surgical intervention, when following established guidelines, can be performed with reasonable mortality and morbidity.
  • Adherence to anatomical resection and cavity obliteration techniques is crucial for successful outcomes.
  • Multidisciplinary collaboration ensures appropriate patient selection and management strategy.

Conclusions:

  • Surgical management is obligatory for pulmonary aspergilloma.
  • Careful planning and execution of resection and cavity management are key to minimizing complications.
  • This approach allows for effective treatment of invasive pulmonary aspergillosis with acceptable patient outcomes.